Develops anticoagulants for kidney disease patients.
Jun 2026Revenue $1.00K/yrExpenses $14.7M/yr
No trendCash runway ≈ 1.4 years from Jun 2026
Figures by year
When will Talphera be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.00K and expenses $14.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $28.0K | $13.5M | −$13.5M |
| Dec 2024 | $0.00 | $15.3M | −$15.3M |
| Dec 2023 | $651K | $17.5M | −$16.9M |
| Dec 2022 | $0.00 | $25.3M | −$25.3M |
| Dec 2021 | $2.82M | $38.8M | −$36.0M |
| Dec 2020 | $5.42M | $46.4M | −$41.0M |
| Dec 2019 | $2.29M | $56.5M | −$54.2M |
| Dec 2018 | $2.15M | $37.9M | −$35.7M |
| Dec 2017 | $8.00M | $46.7M | −$38.7M |
| Dec 2016 | $17.4M | $49.3M | −$32.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.